Altimmune ALT Current ratio

Current ratio at other companies

Eli LillyLLY

1.4×+0.1×

Merck & Co.MRK

1.3×-0.1×

Madrigal Pharmaceuticals, Inc.MDGL

3.2×-1.9×

VAN

Vivani MedicalVANI

3.2×+0.8×

Viking TherapeuticsVKTX

5.7×-38.5×

Wave Life SciencesWVE

10×+7.4×

FAQ

What is Altimmune's current ratio?

Altimmune (ALT) reported current ratio of 29.6× in Q1 2026.

How has Altimmune's current ratio changed year-over-year?

Altimmune's current ratio increased by 86.5% year-over-year, from 15.8× to 29.6×.

What is the long-term trend for Altimmune's current ratio?

Over 5 years (2020 to 2025), Altimmune's current ratio has grown at a -0.6% compound annual growth rate (CAGR), from 19.2× to 18.5×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.